➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Mallinckrodt
Medtronic

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Fluoropyrimidine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Fluoropyrimidine?

Fluoropyrimidine is an investigational drug.

There have been 244 clinical trials for Fluoropyrimidine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Hoffmann-La Roche, and Eli Lilly and Company.

There are eight hundred and ninety-nine US patents protecting this investigational drug and eight international patents.

Recent Clinical Trials for Fluoropyrimidine
TitleSponsorPhase
A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract TumorsProcessa PharmaceuticalsPhase 1
A Study of RO7121661 and RO7247669 Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the EsophagusHoffmann-La RochePhase 2
Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic AdenocarcinomaHallym University Medical CenterPhase 1/Phase 2

See all Fluoropyrimidine clinical trials

Clinical Trial Summary for Fluoropyrimidine

Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine

See all Fluoropyrimidine clinical trials

US Patents for Fluoropyrimidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoropyrimidine   Try Before You Buy Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA)   Try Before You Buy
Fluoropyrimidine   Try Before You Buy Combination therapies for cancer MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH)   Try Before You Buy
Fluoropyrimidine   Try Before You Buy Tapered looped suture Covidien LP (Mansfield, MA)   Try Before You Buy
Fluoropyrimidine   Try Before You Buy Methods of enhancing antibody-dependent cellular cytotoxicity VentiRx Pharmaceuticals, Inc. (Seattle, WA)   Try Before You Buy
Fluoropyrimidine   Try Before You Buy Dosing regimens for echinocandin class compounds Cidara Therapeutics, Inc. (San Diego, CA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluoropyrimidine

Drugname Country Document Number Estimated Expiration Related US Patent
Fluoropyrimidine World Intellectual Property Organization (WIPO) WO2013071079 2031-11-09   Try Before You Buy
Fluoropyrimidine European Patent Office EP3003316 2033-05-31   Try Before You Buy
Fluoropyrimidine Hong Kong HK1223552 2033-05-31   Try Before You Buy
Fluoropyrimidine Japan JP2016524618 2033-05-31   Try Before You Buy
Fluoropyrimidine Japan JP6720075 2033-05-31   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Medtronic
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.